Generation Sequencing Market by Product Type, Technology, Workflow, Services, Application - Global Forecast to 2030" has been added to ResearchAndMarkets.com's offering. The next-generation sequencing ...
This eBook explores next-generation sequencing (NGS) methods and their applications in neurological and cancer research, with key content from BioTechniques’ digital hub and Taylor & Francis journals, ...
Rapid expansion in clinical applications, rising demand for genomic diagnostics, and increased investment in CRISPR-based ...
Next-generation sequencing (NGS) has transformed genomic research and clinical diagnostics by enabling rapid, high-throughput analysis of genetic material. The application of NGS to formalin-fixed ...
Twice the output, half the runtime, and half the footprint of the UG 100® with greater flexibility and improved genomic coverage Introducing two new high-throughput instrument configurations ...
Life sciences and diagnostics company Revvity has had a busy couple of years, playing a major role in the next-generation sequencing-based screening of newborns to better enable healthcare ...
NEXT-GENERATION sequencing use rose in advanced cancer, but access remained uneven across socioeconomic, racial, and ...
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company ™, and several distinguished researchers will be ...
Next-generation sequencing (NGS), especially long-read DNA sequencing, is transforming infectious organism detection by ...
The rapid evolution of HIV under antiretroviral pressure necessitates ongoing surveillance of drug resistance mutations. Next-generation sequencing (NGS) has emerged as a transformative technology in ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Twist Bioscience Corporation (TWST) (NASDAQ: TWST), a mid-cap growth and value biotech company, today launched the Twist TrueAmp Library Preparation Kit ...
Profusa (PFSA) shares jumped 173% following announcement of $30M equity deal to acquire PanOmics diagnostics platform from BioInsights LLC.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results